Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001628280-24-045463
Filing Date
2024-11-06
Accepted
2024-11-06 08:03:25
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 lenztherapeutics424b3sticka.htm 424B3 1317381
2 lenzlogo1a.jpg GRAPHIC 208008
  Complete submission text file 0001628280-24-045463.txt   1605215
Mailing Address 201 LOMAS SANTA FE DRIVE, SUITE 300 SOLANA BEACH CA 92075
Business Address 201 LOMAS SANTA FE DRIVE, SUITE 300 SOLANA BEACH CA 92075 858-925-7000
LENZ Therapeutics, Inc. (Filer) CIK: 0001815776 (see all company filings)

EIN.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-278393 | Film No.: 241429300
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)